about
Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defectsRegulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acidEvaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineEruptive xanthomas as a cutaneous manifestation of hypertriglyceridemia: a case reportDyslipidemia and its therapeutic challenges in renal transplantationLipid abnormalities in kidney disease and management strategiesTriglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studiesImpact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease.Chromatin-modifying agents convert fibroblasts to OCT4+ and VEGFR-2+ capillary tube-forming cells.Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemiaHypolipidaemic Effects of Gymnema sylvestre on High Fat Diet Induced Dyslipidaemia in Wistar RatsManagement of hypertriglyceridemia in the diabetic patientContralateral needling at unblocked collaterals for hemiplegia following acute ischemic stroke.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementChylomicronemia Syndrome in Pregnancy: a Case Report of an Acute Necrotizing PancreatitisNiacin or ezetimibe for patients with, or at risk of coronary heart diseaseLipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention.Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.Two Adults With Hypertriglyceridemia: How should one manage these persons?(#).Consensus statement on management of dyslipidemia in Indian subjects.Gender differences in cardiovascular disease: hormonal and biochemical influences.Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemiaThe effect of alcohol on postprandial and fasting triglycerides.The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemiaPlasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity.A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy.The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotypeHigh-Fat Diet Alters Serum Fatty Acid Profiles in Obesity Prone Rats: Implications for In Vitro Studies.The Liver Clock Controls Cholesterol Homeostasis through Trib1 Protein-mediated Regulation of PCSK9/Low Density Lipoprotein Receptor (LDLR) Axis.Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway.Polymorphisms in LEP and NPY genes modify the response to soluble fibre Plantago ovata husk intake on cardiovascular risk biomarkers.Adipocyte triglyceride turnover is independently associated with atherogenic dyslipidemia.An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.Dyslipidemia in obesity: mechanisms and potential targetsAge- and sex-related changes in fasting plasma glucose and lipoprotein in cynomolgus monkeysAssociation between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated statesThe SLIM Study: Slo-Niacin® and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia.Serum triglyceride concentrations and cancer risk in a large cohort study in Austria.
P2860
Q24298184-6E5CE250-F6F2-407F-B7EB-9CBC005FB81EQ24594113-C5976757-DC7C-4E13-8F15-A7A3CBFB1236Q24608464-3475037A-1455-4F65-9089-37D43EE8B6CDQ24633032-486B94E7-30EA-412F-989B-135644A4B31BQ26851294-ABE2359D-F919-4AFC-A3BF-C0428617A7E3Q27024982-9887F52A-FA98-4F5A-9072-25C3ED5B84B8Q28281855-B8F171F2-B979-4984-B546-E5F9829CA7C2Q33580249-59EF4CCB-B91C-4919-9B09-065634492742Q33633032-108D8917-D146-4364-A639-942C230B64D7Q33639909-35C29CAE-C374-4959-83C7-DE3A5A89DD38Q33644452-B7CDB692-F7C5-4D48-B8B8-DE0D9813EE0EQ33832080-642E6C40-C8B6-4263-8533-C208D0A74AC1Q33935729-09A160EC-1BEB-4FE6-80B0-96611FDD8AF5Q34095718-1598A9F9-C8DC-4A0C-B2CA-5069857B4071Q34181381-07DA320B-3E92-4636-AC23-A16F9EF4E05DQ34209649-8EF41455-A69A-4A46-BEC3-CE4F388CE426Q34300722-E2EC63FE-AB68-4016-BFFD-B6A4C49E0FCAQ34530349-58232A8B-6AF8-48E7-B0F0-5C45E879D383Q34687470-2472774C-0F82-46E5-9F35-5368717C0A3FQ34707314-AF2909CA-F2F4-445A-8317-8C5E17BF3368Q34980772-B0C19EDF-4178-410E-8F96-8637F2AA9469Q35023822-180E9B69-69E3-4DE6-8C52-884D0D1DC47AQ35026444-4D515CAC-ADFF-48DB-9EA9-EDE7E03192A3Q35042540-F7D2D826-8FF0-4E04-A9FF-647818BB2DCBQ35231818-FBDFCA08-BAAA-4258-B687-0CBB42E67B57Q35332645-FDEA73CC-7752-4BC4-87E2-18FF2A918691Q35335497-1B590A90-3BFB-4DD5-A376-B4D3CC206AEFQ35683911-8D6A3B60-ECB2-4053-A7CE-33599C76038CQ35784769-76EEE992-B683-46A4-B2EE-360D203C88DAQ36073303-C7CA1CBE-4097-41CB-8F0C-D8BEA586FB0FQ36407293-79324ED7-14D2-4F2E-A08F-B107710E2128Q36411221-9BF73309-815B-4B89-98E6-FFC3CEA77A2EQ36502024-E4DC6A9E-D9B2-4173-8B2B-C20F05DC0194Q36519838-BC35F5F5-D757-4719-8415-CB07C55654AEQ36745050-BB600582-8195-42A0-9F4B-AD6A594D44ADQ36994072-B82A2A0D-C39E-4F59-8881-48B403C62589Q37035456-AD614018-6AD8-4257-9F7F-7F9E258198A3Q37109483-E5A0E12E-83F0-463F-B45E-DF39D7D44B45Q37375879-9398BE63-BFF3-4ADA-9C74-F7798198FB54Q37400537-87A65482-F89B-4189-808E-CE955F798206
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical practice. Hypertriglyceridemia.
@en
type
label
Clinical practice. Hypertriglyceridemia.
@en
prefLabel
Clinical practice. Hypertriglyceridemia.
@en
P356
P1476
Clinical practice. Hypertriglyceridemia.
@en
P2093
John D Brunzell
P304
P356
10.1056/NEJMCP070061
P407
P577
2007-09-01T00:00:00Z